Immucell Corp (ICCC) earnings
Quarterly results of Immucell Corp as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Immucell Corp reported revenue of $7.2M (+11.5% on the same quarter a year earlier) and net income of $1.8M (+265.6% on the same quarter a year earlier).
Diluted earnings per share were $0.20 (+233.3% on the same quarter a year earlier).
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | $7.2M | +11.5% | $1.8M | $0.20 |
| Q1 FY2026 | $10.4M | +28.4% | $1.9M | $0.21 |
| Q4 FY2025 | $7.6M | -1.6% | -$2.8M | - |
| Q3 FY2025 | $5.5M | -8.4% | -$139.7K | -$0.02 |
| Q2 FY2025 | $6.4M | - | $501.9K | $0.06 |
| Q1 FY2025 | $8.1M | - | $1.4M | $0.16 |
| Q4 FY2024 | $7.8M | - | $514.6K | - |
| Q3 FY2024 | $6M | - | -$701.7K | -$0.09 |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly results 8-K
- Quarterly results 8-K
- Quarterly report 10-Q
- Annual report (amended) 10-K/A
- Quarterly results 8-K
- Annual report 10-K
What were Immucell Corp's latest quarterly results?
For Q2 FY2026, which ended June 30, 2026, Immucell Corp reported revenue of $7.2M and net income of $1.8M (+265.6% on the same quarter a year earlier). The figures come from its filing with the SEC.
Is Immucell Corp's revenue growing?
Revenue in Q2 FY2026 was $7.2M, up 11.5% from $6.4M in the same quarter a year earlier.
Get an email when ICCC reports
Follow ICCC and we email you its next results the day they are filed, with the numbers explained.